While measurement of plasma BNP concentration has been shown to be useful in the diagnosis of heart failure, its role as a screening test for detection of pre-clinical ventricular remodeling or dysfunction in the general population has not been established. Here we review available population-based studies assessing the predictive characteristics of BNP for the detection of pre-clinical structural heart disease (Stage B Heart Failure).
- Ejection fraction
- Heart failure
- Natriuretic peptides
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine